Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population: The Sentinel Study
Recruiting
N/A
Interventional Study
Cancer Diagnosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 45 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 1,500 (estimated)
- Sponsor
- Dana-Farber Cancer Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this research study is to evaluate the possible benefits of an investigational, but commercially available Galleri multi-cancer early detection (MCED) blood test which is designed to detect many types of cancer early in veterans who have served in the military in active duty. The name of the screening blood test being studied is: -GRAIL Galleri MCED test
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Active-duty or National Guard/Reserves military service for four or more years
* Age ≥ 45
* Received care at a VA facility within past 5 years
* Able to sign informed consent
* Willingness to travel to Dana-Farber Cancer Institute in Boston, MA, for diagnostic testing if scree…
Contacts